 Process GO Term   molting cycle    And related genes <body> Process GO Term molting cycle  and related genes   Total 2409 
Page number 25 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81  
    Gene Name  ORF Name  Function GO Term   Process GO Term   Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     HMG1   YML075C  hydroxymethylglutaryl-CoA reductase (NADPH) activity   ergosterol biosynthesis   endoplasmic reticulum membrane*  YNR009W	YOR102W	  Induces cell to assemble stacks of paired nuclear-associated membranes called karmellae.  3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase isozyme  Null mutant is viable, sensitive to compactin, a competitive inhibitor of HMG-CoA reductase; hmg1 hm     HMG2   YLR450W  hydroxymethylglutaryl-CoA reductase (NADPH) activity   ergosterol biosynthesis   endoplasmic reticulum membrane*  YOL113W	  Induces cells to assemble peripheral ER membrane arrays and short nuclear-associated membrane stacks  3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase isozyme  Null mutant is viable, sensitive to compactin, a competitive inhibitor of HMG-CoA reductase; hmg1 hm     HMLALPHA1   YCL066W  transcription co-activator activity   regulation of transcription from Pol II promoter*   nucleus  YDR224C	YBL002W	YJR091C	YLR288C	  transcription factor involved in the regulation of alpha-specific genes  involved in the regulation of alpha-specific genes|transcription factor       HMLALPHA2   YCL067C  transcription co-repressor activity   regulation of transcription from Pol II promoter*   nucleus  YOL006C	YLR288C	  Homeobox-domain containing protein which, in haploid cells, acts with MCM1 to repress a-specific gen         HMT1   YBR034C  protein-arginine N-methyltransferase activity   mRNA-nucleus export*   nucleus  YDR432W	YMR048W	YGR118W	YDR249C	YER017C	YGR165W	YGR181W	YIL061C	YNL078W	  hnRNP methyltransferase  arginine methyltransferase|mono- and asymmetrically dimethylating enzyme  Null mutant is viable, hmt1 npl3-1 mutants are inviable     HNT1   YDL125C  hydrolase activity*   nucleotide metabolism   cytoplasm  YER075C	YJR091C	  Hint homolog, member of the histidine triad superfamily of nucleotide-binding proteins         HNT2   YDR305C  hydrolase activity*   nucleoside catabolism   cellular_component unknown  YLR447C	  Fhit homolog, member of the histidine triad superfamily of nucleotide binding-proteins         HOC1   YJR075W  alpha-1,6-mannosyltransferase activity*   cell wall mannoprotein biosynthesis*   mannosyltransferase complex  YLR338W	YNR005C	YDR129C	YBL007C	YDR388W	YOR089C	YJL095W	YLR087C	YOR035C	YPL050C	YNL322C	YEL031W	YLR337C	YMR198W	YKR020W	YML071C	YNR051C	YJL148W	YBL047C	YML115C	YJR043C	YAL002W	YMR060C	YJL176C	YKR082W	YJR084W	YBR082C	YJR145C	YHR013C	YGR133W	YML097C	YP  Homologous to OCH1, an alpha-1,6-mannosyltransferase; Golgi-localized, type II integral membrane pro  mannosyltransferase (putative)  Null mutant is viable but is hypersensitive to calcofluor white and hygromycin B and has lowered res     HOG1   YLR113W  MAP kinase activity   protein amino acid phosphorylation*   nucleus*  YBL083C	YLR358C	YNL171C	YNL296W	YPR045C	YMR089C	YJL183W	YMR198W	YOR123C	YGR092W	YNL215W	YDR359C	YLR362W	YMR272C	YBR194W	YDR363W-A	YGL200C	YLR398C	YKL041W	YKL194C	YMR172W	YML097C	YDR414C	YJL128C	YDR497C	YNL264C	YPL180W	YGL158W	YLR248W	YDL235C	YGR058W	  Osmoregulation. Hog1p is activated under stress conditions when the cAMP cellular content is low.  MAP kinase  Null mutant is viable and unable to grow in high osmolarity media     HOM2   YDR158W  aspartate-semialdehyde dehydrogenase activity   methionine metabolism*   cellular_component unknown  YCR030C	YLR314C	YDL101C	YBR055C	  threonine and methionine pathway  aspartic beta semi-aldehyde dehydrogenase  Homoserine requiring     HOM3   YER052C  aspartate kinase activity   methionine metabolism*   cellular_component unknown  YIR014W	YKR079C	YMR263W	YNL135C	YER037W	YIR018W	YDL059C	YMR139W	YLR293C	  First step in common pathway for methionine and threonine biosynthesis  aspartate kinase (L-aspartate 4-P-transferase) (EC 2.7.2.4)  Homoserine requiring; Borrelidin resistance     HOM6   YJR139C  homoserine dehydrogenase activity   methionine metabolism*   cellular_component unknown  YLR208W	YDR388W	  catalyzes third step in common pathway for methionine and threonine biosynthesis  L-homoserine:NADP oxidoreductase|homoserine dehydrogenase  Homoserine requiring     HOS3   YPL116W  histone deacetylase activity   histone deacetylation   nucleus*    Protein with similarity to Hda1p, Rpd3p, Hos2p, and Hos1p         HOS4   YIL112W  NAD-dependent histone deacetylase activity*   histone deacetylation*   histone deacetylase complex  YDR155C	YMR273C	YBR103W	YNL298W	YJL168C	           HOT1   YMR172W  specific RNA polymerase II transcription factor activity   regulation of transcription from Pol II promoter*   nuclear chromosome  YOR039W	YIL035C	YLR113W	YGR078C	YML094W	  high osmolarity induced transcription  nuclear protein  osmostress hypersensitivity     HPA2   YPR193C  histone acetyltransferase activity   histone acetylation   cytoplasm  YEL042W	YML064C	YNL189W	YPL070W	YCL032W	  Histone and other Protein Acetyltransferase; Has sequence homology to known HATs and NATs  histone acetyltransferase  Null mutant is viable and does not show any detectable phenotype     HPA3   YEL066W  histone acetyltransferase activity   histone acetylation   cellular_component unknown  YHR041C	YEL066W	YPL112C	YLR347C	YML064C	YNL189W	YPL070W	  Histone and other Protein Acetyltransferase; Has sequence homology to known HATs and NATs    Null mutant is viable and does not show any detectable phenotype     HPC2   YBR215W  transcription regulator activity   G1/S-specific transcription in mitotic cell cycle   nucleus  YLR453C	YKL113C	YLR418C	YLR103C	YDR052C	  Protein required for normal cell-cycle regulation of histone gene transcription  highly charged basic protein  altered cell cycle regulation of histone gene transcription; suppresses delta insertion mutations in     HPR1   YDR138W  nucleic acid binding   mRNA-nucleus export*   THO complex  YEL060C	YDR214W	YLR234W	YOL006C	YML062C	YNR031C	YNL139C	YDL084W	YKR010C	YBR175W	YCL011C	YNL088W	  Hyperrecombination protein that suppresses intrachromosomal excision recombination    Increased intrachromosomal recombination     HPT1   YDR399W  hypoxanthine phosphoribosyltransferase activity   purine nucleotide biosynthesis   cellular_component unknown  YDL130W	YNL189W	  enzyme involved in de novo purine biosynthesis  hypoxanthine guanine phosphoribosyltransferase  Null mutant is viable; mutants show resistance to 8-azaguanine     HRB1   YNL004W  molecular_function unknown   protein-nucleus import   nucleus*  YOR160W	YBR270C	YJR082C	YKL139W	YIL079C	  an ORF of unknown function located in a centromeric region duplicated between chromosomes III and XI  hypothetical RNA-binding protein       HRD1   YOL013C  ubiquitin-protein ligase activity   ER-associated protein catabolism   endoplasmic reticulum membrane    Ubiquitin-protein ligase for endoplasmic reticulum-associated degradation.    Null mutant is viable, slows degradation of Hmg2p     HRD3   YLR207W  ubiquitin-protein ligase activity   ER-associated protein catabolism   endoplasmic reticulum  YPL022W	  HMG-CoA Reductase Degradation--the HRD complex is responsible for the endoplasmic reticulum (ER)-ass    Null mutant is viable, slows degradation of Hmg2p     HRP1   YOL123W  cleavage/polyadenylation specificity factor activity   mRNA polyadenylation*   nucleus*  YFL018C	YDR023W	YMR061W	YGL044C	YDL060W	YGL122C	YMR064W	YMR282C	YDR350C	YBR017C	YCL032W	  Putative polyadenylated-RNA-binding protein located in nucleus; similar to vertebrate hnRNP A/B prot  cleavage and polyadenylation factor CF I component involved in pre-mRNA 3'-end processing  Null mutant is inviable; mutants can suppress temperature-sensitive alleles of npl3 (but not npl3 nu     HRT1   YOL133W  protein binding*   ubiquitin-dependent protein catabolism*   nucleus*  YAR009C	YLR035C-A	YLL034C	YIL001W	YJL200C	YHR027C	YGR240C	YCR093W	YDR216W	YBR208C	YOR261C	YGR218W	YOR326W	YJL020C	YLR106C	YEL034W	YJL047C	YGL195W	YBR126C	YMR246W	YDL132W	YLL039C	YGL137W	YLL040C	YNL037C	YLR289W	YJL141C	YOR341W	YNL085W	YPL036W	YDR009W	  High level expression Reduces Ty3 Transposition  Skp1-Cullin-F-box ubiquitin protein ligase (SCF) subunit  Null mutant is inviable.     HSE1   YHL002W  protein binding   protein-vacuolar targeting   endosome  YNR005C	YGR268C	YDR259C	YNR006W	YNL015W	YGR078C	YEL003W	YLR330W	  Has Symptoms of class E vps mutant    Null: accumulates enlarged prevacuolar/endosomal compartment. Fails to sort proteins into the vacuol     HSF1   YGL073W  transcription factor activity   regulation of transcription from Pol II promoter*   nucleus  YBR160W	  heat shock transcription factor  heat shock transcription factor  Null mutant is inviable     HSH155   YMR288W  mRNA binding   spliceosome assembly   snRNP U2  YML049C	YMR213W	YMR240C	YDL087C	YAL032C	YFL017W-A	YPR182W	YBR152W	  U2-snRNP associated splicing factor that forms extensive associations with the branch site-3' splice         HSH49   YOR319W  RNA binding   nuclear mRNA splicing, via spliceosome   snRNP U2  YHR209W	YDR155C	YGL244W	YML049C	YBR103W	YGR056W	YER164W	YPR188C	YLR233C	YNL135C	YMR240C	YJR022W	YGL096W	  Human SAP Homolog 49. A yeast homolog of a human spliceosome associated protein (SAP) called SAP 49.  mammalian splicing factor/U2 snRNP protein homolog       HSL1   YKL101W  protein kinase activity   protein amino acid phosphorylation*   bud neck*  YBR133C	YNL132W	YGL116W	YPR135W	YMR078C	YCL016C	YDL017W	YNL250W	  Negative regulator of Swe1 kinase  kinase domain similar to GIN4 and KCC4|serine-threonine kinase|similar to S. pombe cdr1/nim1  Null mutant is viable; synthetically lethal with histone H3 mutations; G2 delay   </body> 